Company intelligence / Profile preview

Instituto Bernabeu

Alicante, Valencia, Spain

Ownership: Private
Employees: ~258
Development stage: Other

Overview

Instituto Bernabeu is considered a reference institution in reproductive medicine for its clinical outcomes, pioneering personalized fertility treatments, successful use of PGD for preventing hereditary diseases, and adoption of the latest ART techniques. Success rates vary per indication, with data published regularly; >400 research projects since inception, including world firsts in specific genetic disease-free births.

Therapeutic areas: Women's HealthOphthalmologyMen's HealthRare Diseases
Modalities: Assisted reproductive technology (ART)IVF (In vitro fertilization)ICSI (Intracytoplasmic sperm injection)Preimplantation genetic diagnosis (PGD)
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on Instituto Bernabeu.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Instituto Bernabeu.

Explore the full profile